Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea
Status:
COMPLETED
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Investigation of the effectiveness of intradermal botulinum toxin A treatment in the treatment of erythematotelangiectatic rosacea (ETR) using clinical, biophysical, dermatoscopic and videocapillaroscopy.